GGrantIndex
← Leaderboards

Bing Zhang

Vanderbilt University

$17,138,977
Attributed
$18,105,977
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,105,977 · 8

By mechanism

U24$13,746,124 · 3
R01$2,537,244 · 2
U01$1,353,598 · 2
P50$469,011 · 1

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Proteomics

Research focus

ProteomicsProteinsData SetData AnalysesPathway InteractionsTumorMolecularGenomicsProgramsResourcesMalignant NeoplasmsMass Spectrum AnalysisTranscriptomicsProteogenomicsPhenotypeResearch PersonnelPublishingCollaborationsBaseBiological MarkersCancer TypeGenomeSpecimenFunding

Grant awards (30)

iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$881,719
U24 · FY2025 · CA · contact PI
Translating Pediatric Cancer Proteogenomic Data into Biological and Clinical Insights$640,150
U24 · FY2025 · CA · contact PI
Advancing Protein Isoform Analysis through an Integrated Computational Framework.$398,398
U01 · FY2025 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$788,503
U24 · FY2024 · CA · contact PI
Proteogenomics-driven therapeutic discovery in hepatocellular carcinoma$193,801
R01 · FY2024 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$864,084
U24 · FY2023 · CA · contact PI
Illuminating understudied druggable proteins using pan-cancer proteogenomics data$480,000
U01 · FY2023 · CA · contact PI
Proteogenomics-driven therapeutic discovery in hepatocellular carcinoma$199,920
R01 · FY2023 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$896,717
U24 · FY2022 · CA · contact PI
Illuminating understudied druggable proteins using pan-cancer proteogenomics data$475,200
U01 · FY2022 · CA · contact PI
Proteogenomics-driven therapeutic discovery in hepatocellular carcinoma$199,920
R01 · FY2022 · CA · contact PI
Proteogenomics-driven therapeutic discovery in hepatocellular carcinoma$204,000
R01 · FY2021 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$973,045
U24 · FY2020 · CA · contact PI
Proteogenomics-driven therapeutic discovery in hepatocellular carcinoma$204,000
R01 · FY2020 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$933,338
U24 · FY2019 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$973,045
U24 · FY2018 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$973,045
U24 · FY2017 · CA · contact PI
iPGDAC, An Integrative Proteogenomic Data Analysis Center for CPTAC$1,004,827
U24 · FY2016 · CA · contact PI
Bioinformatics/Biostatistics Core$91,906
P50 · FY2016 · MH · contact PI
Vanderbilt Proteome Characterization Center$1,597,507
U24 · FY2015 · CA · contact PI
Vanderbilt Proteome Characterization Center$475,412
U24 · FY2015 · CA · contact PI
Bioinformatics/Biostatistics Core$93,346
P50 · FY2015 · MH · contact PI
Vanderbilt Proteome Characterization Center$2,744,732
U24 · FY2014 · CA · contact PI
Bioinformatics/Biostatistics Core$94,473
P50 · FY2014 · MH · contact PI
Bioinformatics/Biostatistics Core$91,713
P50 · FY2013 · MH · contact PI
Systems Approach to the Biological Basis of Colon Cancer Metastases$382,239
R01 · FY2012 · GM · contact PI
Bioinformatics/Biostatistics Core$97,573
P50 · FY2012 · MH · contact PI
Systems Approach to the Biological Basis of Colon Cancer Metastases$382,239
R01 · FY2011 · GM · contact PI
Systems Approach to the Biological Basis of Colon Cancer Metastases$383,625
R01 · FY2010 · GM · contact PI
Systems Approach to the Biological Basis of Colon Cancer Metastases$387,500
R01 · FY2009 · GM · contact PI